DK1576951T3 - Sammensætninger til rektal indgivelse af trombolytisk aktive midler - Google Patents

Sammensætninger til rektal indgivelse af trombolytisk aktive midler

Info

Publication number
DK1576951T3
DK1576951T3 DK03767381T DK03767381T DK1576951T3 DK 1576951 T3 DK1576951 T3 DK 1576951T3 DK 03767381 T DK03767381 T DK 03767381T DK 03767381 T DK03767381 T DK 03767381T DK 1576951 T3 DK1576951 T3 DK 1576951T3
Authority
DK
Denmark
Prior art keywords
compositions
active agents
rectal administration
thrombolytically active
thrombolytically
Prior art date
Application number
DK03767381T
Other languages
English (en)
Inventor
Miragaya Maria Acelia Marrero
Barreto Ana Aguilera
Diaz Eduardo Martinez
Cabrera Beatriz Torrez
Mayea Milesa Y Josef Sarmiento
Santos Beatriz Calle E Tamargo
Chavez Lisette Gonzalez
Diaz Carelia Cosme
Marrero Luciano Fran Hernandez
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of DK1576951T3 publication Critical patent/DK1576951T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03767381T 2002-12-27 2003-12-22 Sammensætninger til rektal indgivelse af trombolytisk aktive midler DK1576951T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20020336A CU23203A1 (es) 2002-12-27 2002-12-27 Formulaciones que contienen agentes de accion trombolitica para su administracion por via rectal
PCT/CU2003/000020 WO2004058219A1 (es) 2002-12-27 2003-12-22 Formulaciones para administrar por vía rectal agentes con acción trombolítica

Publications (1)

Publication Number Publication Date
DK1576951T3 true DK1576951T3 (da) 2009-02-02

Family

ID=40091670

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03767381T DK1576951T3 (da) 2002-12-27 2003-12-22 Sammensætninger til rektal indgivelse af trombolytisk aktive midler

Country Status (19)

Country Link
US (1) US10213379B2 (da)
EP (1) EP1576951B1 (da)
JP (1) JP2006512374A (da)
KR (1) KR100804013B1 (da)
CN (1) CN100335128C (da)
AR (1) AR042646A1 (da)
AT (1) ATE409460T1 (da)
AU (1) AU2003291916B2 (da)
BR (1) BRPI0317780B8 (da)
CA (1) CA2527572C (da)
CU (1) CU23203A1 (da)
DE (1) DE60323874D1 (da)
DK (1) DK1576951T3 (da)
ES (1) ES2315537T3 (da)
MX (1) MXPA05007006A (da)
MY (1) MY142241A (da)
PT (1) PT1576951E (da)
WO (1) WO2004058219A1 (da)
ZA (1) ZA200505399B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1660429B (zh) * 2005-01-10 2011-09-07 王振军 基质金属蛋白酶(mmp)抑制剂用于治疗痔的新用途
CN100364610C (zh) * 2005-12-12 2008-01-30 北京大学 提高蚓激酶口服吸收生物利用度的方法
CN102091326B (zh) * 2009-12-15 2013-04-03 上海凯茂生物医药有限公司 治疗因肛门皮下的静脉丛发生扩大或曲张所引发的痔类疾病的经皮给药制剂及制备方法
CN102552916B (zh) * 2010-12-09 2014-04-23 上海凯茂生物医药有限公司 水杨酸钠的新用途
ES2688119T3 (es) * 2015-07-08 2018-10-31 Dr. Falk Pharma Gmbh Formulación farmacéutica para el tratamiento de cambios inflamatorios del recto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8808810D0 (en) 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
US5098707A (en) * 1989-07-31 1992-03-24 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5720962A (en) * 1995-10-04 1998-02-24 Au Pharmaceuticals, Inc. Analgesic lotion for hemorrhoids and method of making such lotion
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
EP1021195A1 (en) * 1997-10-07 2000-07-26 The Regents Of The University Of California Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine
WO2001022935A1 (en) * 1999-09-27 2001-04-05 Oh Jun Suk Use of analgesics as digestive and medicines for expectorating and transdermal therapeutic system using the same

Also Published As

Publication number Publication date
WO2004058219A1 (es) 2004-07-15
AR042646A1 (es) 2005-06-29
CA2527572A1 (en) 2004-07-15
ATE409460T1 (de) 2008-10-15
MY142241A (en) 2010-11-15
EP1576951A1 (en) 2005-09-21
ES2315537T3 (es) 2009-04-01
DE60323874D1 (de) 2008-11-13
EP1576951B1 (en) 2008-10-01
KR20050088219A (ko) 2005-09-02
CU23203A1 (es) 2007-05-18
KR100804013B1 (ko) 2008-02-18
AU2003291916B2 (en) 2007-03-08
CA2527572C (en) 2010-03-30
US20070166298A1 (en) 2007-07-19
BR0317780A (pt) 2005-11-22
BRPI0317780B8 (pt) 2021-05-25
BRPI0317780B1 (pt) 2018-11-21
CN100335128C (zh) 2007-09-05
JP2006512374A (ja) 2006-04-13
PT1576951E (pt) 2009-01-09
CN1738602A (zh) 2006-02-22
MXPA05007006A (es) 2005-08-18
ZA200505399B (en) 2006-04-26
AU2003291916A1 (en) 2004-07-22
US10213379B2 (en) 2019-02-26

Similar Documents

Publication Publication Date Title
DK1480644T3 (da) Heterocykliske forbindelser, der er aktive som inhibitorer af beta-lactamaser
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
DK1608407T3 (da) Dispergébar formulering af et antiinflammatorisk middel
DK3395339T3 (da) Hurtigt opløsende formulering af cinacalcet-hcl
DK1542977T3 (da) 2,5-dioxoimidazolidin-4-ylacetamider og analoger som inhibitorer af metalloproteinase MMP12
DK1309327T3 (da) Farmaceutiske sammensætninger af østrogene midler
DK2158905T3 (da) Sammensætning til transdermal administration af fentanyl
NO20014837D0 (no) Pyrazolsammensetninger nyttige som inhibitorer av ERK
DK1505998T3 (da) Forbedret anvendelse af hop-syrer som antimikrobielle midler
SE0701538L (sv) Azaspiroalkanderivat som hämmare av metalloproteaser
PT1585548T (pt) Composições e métodos de administração de agentes farmacológicos
DK1485127T3 (da) Anvendelse af midler til behandling af inflammation
DK2039685T3 (da) Heterobicycliske forbindelser som P38-inhibitorer
FR2873585B1 (fr) Nouvelles formulations galeniques de principes actifs
DK1478339T3 (da) Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf
IS8483A (is) Heterósýklísk virk efni gegn mígreni
EE200300088A (et) Imidasolo-5-üül-2-anilino-pürimidiinid raku proliferatsiooni inhibitsiooni agensitena
DK1132570T3 (da) Sammensætninger til syrebehandling af borebrönde
DK1567529T4 (da) Pseudopolymorfe former af en hiv-proteaseinhibitor
DK1458447T3 (da) Kombination af cytokrom-p450-beroende proteasinhibitorer
DK1601359T3 (da) Væskeformige, farmaceutiske formuleringer af palonosetron
DK1600441T3 (da) Krystallinsk form af elrcanidipinhydrochlorid til anvendelse som et antihypertensivt middel
DK1401828T3 (da) N-Formylhydroxylaminforbindelser som inhibitorer af PDF
DK1764111T3 (da) Vaginalt indgivne anti-dysrytmi midler til behandling af uterin dysrytmi
FI20040462L (fi) Tehopuolijohdekomponenttien suojaus